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MicroRNAs (miRNAs) control gene expression by
translational inhibition and destabilization of mRNAs.
While hundreds of miRNAs have been found, only a
few have been studied in detail. miRNAs have been im-
plicated in tissue morphogenesis, cellular processes
like apoptosis, and major signaling pathways. Emerg-
ing evidence suggests a direct link between miRNAs
and disease, and miRNA expression signatures are
associated with various types of cancer. In addition,
the gain and loss of miRNA target sites appears to be
causal to some genetic disorders. Here, we discuss
the current literature on the role of miRNAs in animal
development and disease.
Introduction
Four types of silencing-related small RNAs have been
found in animals over the past few years: small inter-
fering RNAs (siRNAs), microRNAs (miRNAs), and, more
recently, repeat associated small interfering RNAs
(rasiRNAs) and Piwi-interacting RNAs (piRNAs).
siRNAs are usually derived from double-stranded
RNA, which originates from viruses or overlapping tran-
scripts. Generally, siRNAs trigger mRNA degradation by
binding to their targets with perfect complementarity
(reviewed by Meister and Tuschl, 2004).
Genomic repeats and retrotransposons give rise to
rasiRNAs, and these havebeen found inDrosophila (Vagin
et al., 2006; Saito et al., 2006). Interestingly, rasiRNAs
arise primarily from the antisense strand of genomic re-
peats, and they seem to function through a distinct small
RNA pathway involving Piwi proteins in flies.
A germline-specific class of vertebrate small RNAs is
formed by piRNAs, which are 29–30 nt-long RNAs that
act by binding to Piwi proteins. piRNAs are not associ-
ated with repeats; however, the encoding genes are
localized in clusters in the genome, and piRNAs within
a cluster map to only one strand of the genomic DNA
(reviewed by Kim, 2006).
miRNAs are currently well established as a class of
w22 nt endogenous, noncoding small RNAs that influ-
ence mRNA stability and translation. Although the first
miRNA, lin-4, was found in 1993 (Lee et al., 1993; Wight-
man et al., 1993), it took until 2000 before the miRNA field
took off after the discovery of the highly conserved let-7
small RNA (Reinhart et al., 2000).
*Correspondence: plasterk@niob.knaw.nlSince then, several groups have applied small-
RNA-cloning strategies to identify new small RNAs in
vertebrates and invertebrates (Lau et al., 2001; Lee and
Ambros, 2001; Lagos-Quintana et al., 2001). More re-
cently, hundreds of miRNAs have been found in many
animal species by computational predictions, experi-
mental approaches, or combined strategies (reviewed
by Berezikov et al., 2006).
miRNA genes are transcribed by RNA polymerase II as
capped and polyadenylated primary miRNA transcripts
(pri-miRNA) (Cai et al., 2004; Lee et al., 2004). The RNase
III enzyme Drosha initiates the nuclear processing of the
pri-miRNA into anw70 nt precursor miRNA (pre-miRNA)
(Lee et al., 2003) (Figure 1). The double-stranded RNA
binding protein DGCR8 interacts with Drosha to form
the microprocessor complex (reviewed by Kim, 2005).
Pre-miRNAs are exported from the nucleus by binding
to the nucleocytoplasmic transport factor Exportin-5
(reviewed by Kim, 2004). Maturation of the pre-miRNA
into an imperfect RNA duplex, with 2 nt 30 overhangs,
is mediated by the cytoplasmic enzyme Dicer (reviewed
by Hammond, 2005). The strand of the duplex with the
weakest base pairing at its 50 terminus is preferably
loaded into the RNA-induced silencing complex (RISC)
(reviewed by Hutvagner, 2005).
The miRNA guides the RISC complex to the 30UTR of
target mRNAs. Animal miRNAs usually base pair with
imperfect complementarity to their target. The seed re-
gion (nucleotides 2–8) of miRNAs is most important for
target recognition and silencing (Lewis et al., 2005;
Doench and Sharp, 2004). Association of miRNAs with
their target mRNAs inhibits translation, but data on the
exact mechanism of translational repression remain
unclear due to the fact that both the initiation and elon-
gation steps of translation are thought to be affected
(Pillai et al., 2005; Petersen et al., 2006; reviewed by
Valencia-Sanchez et al., 2006). Repressed mRNAs are
present in cytoplasmic foci called P-bodies, which are
known sites of mRNA destabilization (reviewed by Bruno
and Wilkinson, 2006). Recent data suggest that, indeed,
miRNA-mediated repression might have a profound im-
pact on target mRNA levels, possibly via de-adenylation
of the mRNA (Bagga et al., 2005; Lim et al., 2005; Giral-
dez et al., 2006; Valencia-Sanchez et al., 2006).
Recent advances in analyzing the spatial expression of
miRNAs have shown that miRNAs are expressed in a
very tissue-specific manner during development (Wien-
holds et al., 2005; Kloosterman et al., 2006; Ason et al.,
2006; Aboobaker et al., 2005). This indicated that miRNAs
are possibly involved in specifying and maintaining tis-
sue identity. The conservation in expression of miR-1,
for example, in muscles; miR-124 in the central nervous
system; andmiR-10 in anterior-posterior patterning sug-
gests that the functions of these and possibly many other
miRNAs have been conserved (also see Figure 2).
Functions of miRNAs
Loss of All miRNAs
From their conservation and expression patterns, it is
clear that miRNAs might play important roles in
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cannot live or reproduce (Bernstein et al., 2003; Ketting
et al., 2001; Wienholds et al., 2003). Mice deficient in
Dicer die at embryonic day 7.5 and lack multipotent
stem cells (Bernstein et al., 2003). In addition, condi-
tional inactivation of Dicer in embryonic stem cell lines
compromises proliferation and differentiation; however,
these effects might also be attributed to changes in cen-
tromeric silencing rather than to compromised miRNA
production (Kanellopoulou et al., 2005; Murchison
et al., 2005). Also, Drosophila mutants lacking Dicer-1
in the germline stem cells show that the miRNA pathway
is essential for stem cell division and to bypass the G1/S
checkpoint of the cell cycle (Hatfield et al., 2005). How-
ever in zebrafish, Dicer-deficient primordial germ cells
were transferred to wild-type embryos, and these could
grow into fertile zebrafish including a germline that lacks
Dicer and miRNAs (Giraldez et al., 2005). Together, these
data show that not all organisms employ the same mech-
anisms to proliferate and differentiate pluripotent stem
cells, and that, at least in zebrafish, Dicer and miRNAs
are not required for germline stem cell development.
Although the zebrafish zygotic Dicer mutant lives for
almost 2 weeks due to maternally contributed Dicer
(Wienholds et al., 2003), analysis of the maternal zygotic
Figure 1. Schematic Overview of miRNA Biogenesis and Mecha-
nism of ActionDicer mutant embryos showed that zebrafish can differ-
entiate multiple cell types in early development without
miRNAs, but that morphogenetic processes are severely
affected (Giraldez et al., 2005). Several conditional
approaches to knock out Dicer in the mouse have been
taken to circumvent the embryonic lethality of Dicer
null mutants. These studies have indicated that Dicer,
and probably also miRNAs, is essential for morphogene-
sis of the skin (Andl et al., 2006; Yi et al., 2006), lung
epithelium (Harris et al., 2006), and the vertebrate limb
(Harfe et al., 2005).
miRNAs as Regulators of Developmental Timing
The first miRNA, lin-4, was discovered in C. elegans as
a small RNA species with antisense complementarity
to the heterochronic gene lin-14 (Lee et al., 1993; Wight-
man et al., 1993). Negative posttranscriptional regula-
tion of lin-14 by lin-4 is essential for the formation of a
temporal gradient of the LIN-14 protein, ensuring proper
transition between C. elegans larval stages. Besides
lin-14, the heterochronic gene lin-28 is also a target of
lin-4. lin-28 homologs also exist in animals, including
mouse and human. The lin-28 30UTR harbors target sites
for miR-125a and let-7b (homologs of C. elegans lin-4
and let-7) and is expressed and downregulated during
development (Moss and Tang, 2003).
The let-7 miRNA regulates heterochronic genes in
a similar manner as lin-4, and the complementary ele-
ments conferring regulation by let-7 are in some cases
evolutionarily conserved, e.g., lin-41 (Pasquinelli et al.,
2000). Together with the finding that let-7 regulates the
C. elegans hunchback homolog hbl-1 and several other
transcription factors during the larval-to-adult transi-
tion, this indicates that let-7 acts as a master switch con-
trolling temporal patterning (Abrahante et al., 2003;
Grosshans et al., 2005; Lin et al., 2003). However, the
let-7 family miRNAs miR-48, miR-84, and miR-241 also
play a role in the C. elegans heterochronic pathway to
control cell fate transitions (Li et al., 2005).
miRNAs Involved in Signaling Pathways
Although a role in developmental timing appeared to be
the critical function for the lin-4 miRNA, recently a role
was proposed for lin-4 in regulating life span, possibly
through the insulin/insulin-like growth factor-1 pathway
(Boehm and Slack, 2005). Overexpression of lin-4 re-
sulted in a prolonged life span, and lin-4 loss-of-function
mutations caused premature death. These data suggest
a dual function for lin-4 in controlling developmental
timing during embryonic development and affecting
life span through a major signaling pathway.
The Notch signaling pathway is essential for pattern-
ing and development, and studies in Drosophila have
shown that Notch-targeted genes are regulated byFigure 2. Expression of miR-124a and miR-1
in Zebrafish, Medaka, Mouse, and Fly
The expression of miR-124a is restricted to
the brain and the spinal cord in fish and
mouse or to the ventral nerve cord in the fly.
The expression of miR-1 is restricted to the
muscles and the heart in the mouse. The con-
served sequence and expression of miR-1
and miR-124a suggests ancient roles in
muscle and brain development. The fly and
medaka pictures were generously provided
by Eric Lai and Brandon Ason, respectively.
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expression of some of these miRNAs induces pheno-
types that are reminiscent of Notch pathway loss of func-
tion. This repression of Notch-induced transcripts might
be necessary to prevent their overexpression.
Several positive and negative-feedback loops exist
that incorporate miRNAs. The C. elegans miRNA miR-61
isa direct transcriptional target ofLIN-12/Notch and func-
tions in a positive-feedback loop promoting a secondary
vulval cell fate, thus suggesting thatmiR-61plays a major
role in specifying cell fate (Yoo and Greenwald, 2005).
Photoreceptor differentiation in the Drosophila eye is
mediated bymiR-7. This miRNA functions in a reciprocal
negative-feedback loop to inhibit the expression of the
YAN protein, which acts as a transcriptional repressor
of miR-7. The expression of miR-7 is initially triggered
by EGF signaling, which results in phosphorylation
and inactivation of YAN, generating a stable change in
gene expression (Li and Carthew, 2005). Thus, major
signaling pathways may induce changes in gene expres-
sion in the first place, but may use miRNAs to stabilize
the resulting expression program. It is still unclear
through which target genes outside the feedback loop
miR-7 promotes photoreceptor differentiation.
Although not directly related to signaling, miRNAs
more often reside in feedback loops to control their own
expression. Granulocytic differentiation is enhanced by
miR-223 expression (Fazi et al., 2005). Before the differ-
entiation process, the transcription factor NFI-A allows
weak expression of miR-223. Upon stimulation with ret-
inoic acid, NFI-A is replaced by the transcription factor
C/EBPa, which induces high expression of miR-223,
which, in turn, represses the expression of NFI-A post-
transcriptionally in a manner similar to miR-7 and YAN.
The expression of miR-7 in flies and miR-61 in worms
is induced by EGF and Notch signaling, respectively.
However, miRNAs might also function upstream of sig-
naling pathways. Hoxb8 is a transcription factor that
mediates retinoic acid-induced expression of Sonic
hedgehog, a signaling molecule that regulates anterio-
posterior patterning in limb buds. miR-196 functions as
a secondary regulator of hoxb8 expression in the verte-
brate hindlimb, where the primary level of hoxb8 regula-
tion appears to be transcriptional (Hornstein et al., 2005).
miRNAs in Apoptosis and Metabolism
Forward genetic screens in flies have led to the discov-
ery of miRNAs involved in programmed cell death. The
bantam miRNA accelerates proliferation and prevents
apoptosis by regulating the proapoptotic gene hid
(Brennecke et al., 2003). Similarly, miR-14 functions as
a cell death suppressor, although its cellular target is un-
known (Xu et al., 2003). However, fly miR-14 mutants
display another phenotype: they are obese and have
elevated levels of triacylglycerol. This phenotype shows
that miR-14 plays a role in fat metabolism. In a similar
gain-of-function screen for genes affecting tissue
growth, the miR-278 locus was identified (Teleman
et al., 2006). miR-278 mutants are lean and have ele-
vated insulin production, implicating this miRNA in
energy homeostasis, possibly by interacting with the
expanded transcript, which is known to be involved in
growth control. In vertebrates, miR-375 is expressed in
the pancreatic island and suppresses glucose-induced
insulin secretion (Poy et al., 2004). The myotrophin(Mtpn) gene was validated as a target of miR-375 and
siRNA-mediated knockdown of Mtpn mimicked the
effect of miR-375 on insulin secretion.
miRNAs Involved in Myogenesis and Cardiogenesis
The sequence of miR-1 is conserved from worms to
mammals. It is highly expressed in the muscles of flies
and the muscles and heart of mice (Aboobaker et al.,
2005; Zhao et al., 2005) (Figure 2). Interestingly, a genetic
knockout ofDrosophilamiR-1 does not affect the forma-
tion and physiological function of the larval musculature,
but malformation of the muscles and death are only trig-
gered upon feeding and growth (Sokol and Ambros,
2005). Thus, some miRNAs might not be essential for es-
tablishing a tissue type, but they are required for subse-
quent growth and maintenance of the tissue. In mouse,
miR-1 expression is directed by muscle-differentiation
regulators, such as serum response factor, MyoD, and
Mef2, in the same cells as one of its targets, Hand2
(Zhao et al., 2005). Although there is no genetic knockout
of miR-1 available, overexpression of miR-1 results in
developmental arrest, thin-walled ventricles, and heart
failure due to premature differentiation and proliferation
defects of myocytes.
In cell culture, miR-1 promotes myogenesis by target-
ing histone deacetylase 4 (HDAC4), a transcriptional
repressor of muscle differentiation (Chen et al., 2006).
HDAC4 is also a possible target of miR-140 during oste-
oblast differentiation and skeletogenesis, showing that
two different miRNAs can target the same gene during
differentiation (Tuddenham et al., 2006). miR-1 localizes
in a genomic cluster with miR-133, but these two
miRNAs differ in their seed sequence, and they have dis-
tinct functions (Chen et al., 2006). In contrast to miR-1,
miR-133 inhibits muscle differentiation and promotes
proliferation by repressing serum response factor.
Although miR-181 is hardly detectable in skeletal
muscle, this miRNA is strongly upregulated during myo-
blast differentiation and inhibits the expression of Hox-
A11, which is a repressor of differentiation (Naguibneva
et al., 2006). miR-181 might be involved in establishing
a muscle phenotype, while miR-1 and miR-133 are
involved in muscle maintenance. In addition, miR-181
can induce the differentiation of hematopoietic stem
cells to B-lineage cells, demonstrating a dual role for
a single miRNA in different cell types (Chen et al., 2004).
miRNAs in the Brain
The brain represents a complex tissue, with multiple dif-
ferent cell types. Many miRNAs are expressed in spe-
cific brain regions or neurons in vertebrates, suggesting
their importance in brain functioning (Wienholds et al.,
2005). Some miRNAs have been implicated in specifying
asymmetric gene expression in chemosensory neurons
in C. elegans (Chang et al., 2004; Johnston and Hobert,
2003). The lsy-6 miRNA is expressed in left neurons,
and miR-273 is expressed in right neurons; this recipro-
cal expression is essential for neuronal asymmetry.
In the mammalian brain, miR-134 was found to local-
ize to synaptic sites in rat hippocampal neurons (Schratt
et al., 2006). miR-134 can inhibit the expression of the
protein kinase Limk1, which controls the development
of dendritic spines. The silencing can be released upon
extracellular stimuli, resulting in spine growth.
Another miRNA,miR-132, is expressed in cortical neu-
rons and is a target of the transcription factor
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et al., 2005). Inhibition of miR-132 attenuates neuronal
outgrowth, and the effects on neuronal morphogenesis
might be mediated by the GTPase-activating protein
p250GAP.
Although these two examples propose roles for
miRNAs in neuronal outgrowth and plasticity, miR-
124a is involved in the differentiation of neural progeni-
tors into mature neurons by degradation of nonneural
transcripts (Conaco et al., 2006). miR-124a, together
with miR-9 and miR-132, is targeted by the transcrip-
tional repressor REST in nonneural cells.
The miR-430 family of miRNAs, which is the major
miRNA family expressed during early zebrafish devel-
opment, performs a more general role in zebrafish brain
morphogenesis (Giraldez et al., 2005). In addition, this
miRNA clears the embryo of maternal mRNAs to promote
the maternal-to-zygote transition (Giraldez et al., 2006).
The Expression of miRNAs and Their Targets
The studies of miR-7 and YAN in Drosophila, miR-196
and Hoxb8a in mouse, and miR-223 and NFI-A during
granulopoiesis indicate that miRNAs and their targets
might have reciprocal expression patterns, i.e., if the
miRNA is expressed at a high level, the target is lowly
expressed. This trend toward mutually exclusive ex-
pression of miRNAs and their targets has been shown
on a larger scale by independent studies in mammals
(Farh et al., 2005; Sood et al., 2006) and Drosophila
(Stark et al., 2005). There are five important results
from these studies. First, mRNAs are, in general, ex-
pressed at higher levels prior to miRNA expression. A
very nice biological example of this is the clearance of
maternal mRNAs by the miR-430 family (Giraldez et al.,
2006). Second, nonconserved target sites are preferen-
tially found in genes that are not expressed in the tissue
in which the miRNA is expressed. These might thus be
mRNAs that randomly acquired target sites during evo-
lution, which could persist because there is no selection
against them. Third, conserved targets are expressed in
the tissue in which the miRNA is expressed, but usually
at lower levels compared to the surrounding tissue.
Fourth, mRNAs that are preferentially coexpressed with
an miRNA specifically avoid target sites for that miRNA,
and these are referred to as antitargets. Antitargets
could cooperate with miRNAs to establish the correct
biological environment in a particular cell lineage or
could be involved in basic processes common to all
cells. Fifth, housekeeping genes have shorter UTRs than
other messengers, and the target site density is lower
compared to genes with longer 30UTRs, probably to
avoid targeting by miRNAs.
In principle, there are two ways that miRNAs could
regulate their target (Bartel and Chen, 2004). Fine-tuning
targets contain just one site for one miRNA and confer
only weak regulation. This is the case for the majority of
targets (Stark et al., 2005). In these instances, weak
regulation of a target might become significant when
the target is already expressed at very low levels in the
cell. But why would tuning targets exist in the first place
when, for many genes, there is not even an effect of the
loss of a single allele (resulting in an expected 50%
loss at the protein level)? Probably, these effects are
not meaningful at the level of an individual, but mightonly become apparent from an evolutionary perspective,
where small differences in gene expression affect the
survival of individuals at the population level. The second
class comprises switch targets, where multiple target
sites are present in the 30UTR resulting in strong repres-
sion. These could be target sites for just a single miRNA
or target sites for different miRNAs, resulting in cooper-
ative regulation provided that the miRNAs are expressed
in the same cells. Switch targets could be rare, and the
targets for many genetically identified miRNAs contain
multiple sites, indicating that they are strongly regulated.
In light of the incidence of these two types of miRNA-
mediated regulation, it does not come as a surprise that
developmental defects caused by miRNA knockdown
are limited (Leaman et al., 2005) and that so few miRNAs
have been found in genetic screens. Even without the
miRNA, the expression of its target mRNA seems to re-
main low in the tissue in which the miRNA is expressed
compared to surrounding tissues (Farh et al., 2005). In
addition, many miRNAs are part of families with related
sequence that are potentially involved in the same path-
ways (Abbott et al., 2005). Thus, redundancy also plays
a significant role in miRNA biology. Indeed, many
miRNAs have multiple copies in the genome or reside
in families of related sequence, and these family mem-
bers are often coexpressed from a single transcript
(e.g., miR-182, miR-183, and miR-96 or miR-221 and
miR-222) (Wienholds et al., 2005). Interestingly, there
are not many conserved miRNAs of unrelated sequence
that are coexpressed in the same tissues (Wienholds
et al., 2005). In those cases in which there are over-
lapping expression domains, it would be interesting to
see if there is a higher than random cooccurrence of tar-
get sites for these miRNAs (e.g., miR-1 and miR-133 in
muscles, miR-7 and miR-375 in the endocrine pancreas,
ormiR-183 andmiR-200 in hair cells). On the other hand,
from an evolutionary perspective it seems difficult to un-
derstand how several identical miRNAs could be main-
tained when they play an identical role during develop-
ment. The expression of each of these copies could
vary both in time and in space so that each copy adopts
its own specific function and the pattern obtained with
a probe for the mature miRNA provides a total picture.
Alternatively, the many copies might be essential for
establishing a high concentration of miRNAs inside the
cell that meets the requirement of regulating hundreds
of target genes. Also, the variation in the sequence of
miRNA family members might help in fine tuning the ex-
pression of target genes. Members of the mixed pool of
these related miRNAs could all recognize the same tar-
gets by seed pairing, but they could vary a little in the
overall degree of complementarity, and, together, they
could provide the required degree of regulation.
miRNAs Involved in Cancer
Altered miRNA Expression in Cancer
The initial evidence that miRNAs play a collaborating
role in cancer came from a study on chronic lymphocytic
leukemia (Calin et al., 2002). A region containing miR-15
and miR-16 at chromosome 13q14 is deleted in the
majority of chronic lymphocytic leukemia cases. Follow
up studies indicated that a common feature of human
miRNAs is that they are located at genomic regions in-
volved in cancer, such as common breakpoint regions
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There are two possible scenarios: (1) either the expression level of the miRNA changes due to genomic rearrangements; or (2) there is a gain or
loss of an miRNA-target interaction due to a mutation in a 30UTR or a mutation in the miRNA.and fragile sites (Calin et al., 2004). In addition, among
three cancer types, analysis of the DNA copy number
of genomic regions containing miRNAs identified
26 miRNAs with a gain of gene copy number and 15
miRNAs with a loss (Zhang et al., 2006). It is obvious that
miRNAs located in deleted or amplified regions in cancer
samples have altered expression levels (Figure 3).
From several studies, it is now clear that differential
miRNA expression is associated with tumor formation
(Calin et al., 2004, 2005; Ciafre et al., 2005; Michael
et al., 2003; Lu et al., 2005; Volinia et al., 2006; Yanaihara
et al., 2006). A particularly interesting finding from
a study by Lu et al. (2005) is that both the differentiation
state and the developmental lineage of tumors are re-
flected in the miRNA profile (Lu et al., 2005). The analysis
of parallel mRNA profiling did not lead to a similar clus-
tering of tumor samples derived from the same lineage,
suggesting that miRNA profiling of tumor samples might
be more informative for cancer diagnosis compared to
regular mRNA profiling. Indeed, the analysis of unique
miRNA profiles of lung tumors revealed an important re-
lationship between miRNA expression signatures and
patient survival (Yanaihara et al., 2006). Also, the expres-
sion levels of, e.g., miR-155 in B cell lymphoma patients
and let-7 in lung cancer are indicative for patient sur-
vival, showing that monitoring miRNA expression in can-
cer patients clearly has prognostic value.
Another striking finding presented in the study by
Lu et al. (2005) is that most miRNAs are expressed at
lower levels in tumors compared with normal tissues
(Lu et al., 2005). Thus, a decrease in miRNA levels isassociated with a loss of cellular differentiation. The
widespread downregulation of miRNAs in cancers is
possibly due to a failure at the Drosha-processing step
(Thomson et al., 2006). These data support the sug-
gested role of miRNAs in promoting differentiation and
show that miRNAs can act analogous to tumor-suppres-
sor genes.
Other studies show that some miRNAs are also upre-
gulated in tumors versus normal tissues and thus act as
oncogenes (Ota et al., 2004; Volinia et al., 2006). For ex-
ample, the miR-17-92 cluster is overexpressed in B cell
lymphoma (Ota et al., 2004; He et al., 2005). However,
this cluster comprises some of the few miRNAs ex-
pressed highly in embryonic stem cells, where expres-
sion is decreasing during embryonic development. In
terms of miRNA biology, the miR-17-92 cluster might
be an exception in that it is not associated with differ-
entiation, but rather specifies characteristics of stem
cells, resembling the dedifferentiated state of malig-
nancies.
Although no changes in the expression of genes act-
ing as components of the miRNA machinery were ob-
served in one study (Lu et al., 2005), some lung cancers
were found to have reduced expression ofDicer (Karube
et al., 2005), and ovarian tumors exhibited gains in DNA
copy number of Dicer and Argonaute 2 (Zhang et al.,
2006), suggesting that indirect effects could also ac-
count for altered miRNA expression in tumors.
miRNAs Targeting Cancer-Related Genes
The studies described above clearly indicate that
miRNAs are associated with cancer etiology, but this
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sion is a cause or a consequence of tumor formation.
In principle, miRNA downregulation could lead to in-
creased expression of oncogenes, and miRNA upregu-
lation could prevent the expression of tumor suppres-
sors. When analyzing the miRNA expression profiles of
solid tumors, Volinia and colleagues found that the pre-
dicted targets of 18 miRNAs that are dysregulated in tu-
mors contain a significant overrepresentation of cancer-
related genes (Volinia et al., 2006). For example, TGF-b-2
receptor is expressed in the epithelium of breast cancer
and can be regulated by miR-20a, which is down-
regulated in breast cancer. Several other examples of
miRNAs regulating cancer genes exist. miR-15 and
miR-16 are downregulated in chronic lymphocytic leu-
kemia. Both miRNAs target the antiapoptotic B cell lym-
phoma 2 (Bcl2) protein and can induce apoptosis by
downregulating Bcl2 when expressed in cell lines (Cim-
mino et al., 2005). The let-7 miRNA is expressed at low
levels in human lung cancers (Takamizawa et al.,
2004), and this phenomenon is strongly associated
with a reduced expression of Dicer in lung cancer
(Karube et al., 2005). Furthermore, expression of human
RAS is regulated by let-7 through multiple complemen-
tary sites in its 30UTR, and the expression of let-7 and
RAS is inversely correlated in lung tumors, suggesting
that let-7 may act as a tumor suppressor (Johnson
et al., 2005).
Apart from reduced miRNA expression in tumors, the
overexpression of some miRNAs often promotes tumor
formation. ThemiR-17-92 cluster is amplified in hemato-
poietic malignancies (Ota et al., 2004). Overexpression
of this cluster can act together with c-Myc to accelerate
tumor development in a mouse model for B cell lym-
phoma (He et al., 2005). In addition, induction of the
miR-17-92 cluster by c-Myc reduces expression of anti-
angiogenic proteins, resulting in enhanced tumor angio-
genesis (Dews et al., 2006). How delicately tumor prolif-
eration is controlled is demonstrated by the direct
transcriptional activation of E2F1 and the miR-17-92
cluster by c-Myc, while miR-20a and miR-17-5p, in
turn, negatively regulate E2F1 (O’Donnell et al., 2005).
With the increasing number of human miRNAs that
have been discovered over the past few years, miRNA
overexpression screens can be performed to identify
novel miRNA functions. In a genetic screen, miR-372
andmiR-373were found to allow proliferation of primary
human cells that express oncogenic RAS and active
p53, possibly by inhibiting the tumor suppressor
LATS2 (Voorhoeve et al., 2006). Interestingly, expression
of miR-372 and miR-373 seems to be specifically asso-
ciated with germ cell tumors, as most somatic tumors do
not express these miRNAs. Similar to the miR-17-92
cluster, these miRNAs are highly expressed in ES cells,
implying that their in vivo function is reestablished in
germ cell tumors to induce transformation.
In conclusion, because most miRNAs are thought to
play a role during differentiation and maintenance of
tissue identity, it is expected that the undifferentiated
state of malignant cells is often correlated with a de-
crease in the expression of miRNAs. However, some of
the miRNAs that have a natural function in maintaining
a stem cell fate can be highly expressed during the
transformation.Disease Associated with Changes in the Sequence
of the miRNA or the miRNA Target Site
miRNA Polymorphisms
Is altered miRNA expression, as observed in tumors, the
only mechanism that connects miRNAs to disease?
Apart from changes in miRNA expression levels, the
interaction between the miRNA and its target could be
disturbed due to mutations in either the miRNA itself
or in its target site (Figure 3) (Plasterk, 2006). A mutation
that affects the activity of the miRNA should preferably
be located in the seed sequence of the mature miRNA
(Lewis et al., 2005). To date, no systematic analysis of
polymorphisms in miRNAs among diseased subjects
has been performed, although polymorphisms have
been detected among a cohort of 96 people representing
the general population in Japan (Iwai and Naraba, 2005).
Some single nucleotide polymorphisms (SNPs) were
detected in the loop of the pre-miRNA, and these should
not influence processing (Zeng and Cullen, 2003).
One C-to-A transition in mature miR-30c-2 was de-
tected, but this variant was still processed, and 11 peo-
ple with a heterozygous phenotype appeared healthy. In
contrast, one of the miRNAs from a variant of Kaposi’s
sarcoma-associated herpesvirus (KSHV) contains an
SNP in the precursor stem loop that results in aberrant
processing and, therefore, reduced miRNA function
(Gottwein et al., 2006).
Polymorphisms in miRNA Target Sites
Gene expression is commonly regulated by regulatory
motifs in the 30UTR of mRNAs. In a systematic compar-
ison of 30UTR regions of protein-encoding genes across
the mouse, human, rat, and dog genomes, 106 highly
conserved and frequently occurring motifs were found
(Xie et al., 2005). Strikingly, the length distribution of
these motifs gave a peak at a length of 8 bases and
had a strong tendency to end with an A, reminiscent of
miRNA target sites. About 43.5% of a set of 207 human
miRNAs matched with these conserved 8-mer motifs.
The remaining miRNAs that do not contain complemen-
tary matches to any of the conserved motifs are evolving
much more rapidly and may bind relatively few targets.
Roughly one-half of the conserved motifs found in
30UTRs appear to be related to miRNAs, and 5000 human
genes (20% of the genome) contain conserved motifs, in-
dicating the importance of miRNA-mediated gene regu-
lation. In another study, miRNA targets were predicted
by identifying mRNAs with conserved complementarity
to the seed of the miRNA in four mammalian genomes
(Lewis et al., 2005). A similar number of 5300 human
genes were predicted as miRNA targets. The strong con-
servation of many miRNA target sites indicates that their
regulation is important for cellular processes. Conse-
quently, natural variation in miRNA target sites could
result in aberrant regulation of gene expression, causing
genetic diseases. Alternatively, new miRNA target sites
could arise from mutations in 30UTR sequences.
Variation in a Target Site for miR-189
Tourette’s syndrome (TS) is a genetically influenced
neuropsychiatric disorder that affects as many as 1 in
100 individuals (Abelson et al., 2005). In a search for
candidate genes associated with TS, a patient was iden-
tified with a de novo chromosome 13 inversion. Three
genes were found within the two breakpoints of the
rearrangement, and Slit and Trk-like family member 1
Review
447(SLITRK1) was considered as the most likely candidate
for further study because of its expression in brain re-
gions implicated in TS. Subsequently, the SLITRK1
gene was screened for mutations in 174 affected individ-
uals. Besides a 1 base deletion in the coding region lead-
ing to a frameshift and a truncated protein, two identical
occurrences of a sequence variation that mapped to
a highly conserved nucleotide in the 30UTR of the tran-
script were found. Because the two variations were
found in distinct haplotypes, they probably arose inde-
pendently. The polymorphism was located within the
predicted binding site formiR-189, replacing a G:U wob-
ble base pair with an A:U pairing. In the wild-type situa-
tion, theSLITRK1 30UTR is regulated bymiR-189, but the
regulation is stronger in the variant with the polymor-
phism in the target site. In situ hybridization for miR-
189 and SLITRK1 indicated developmentally regulated
and overlapping expression patterns in neuroanatomi-
cal circuits most commonly implicated in TS. Although
the mutation in the target site for miR-189 is just one
of the many rare mutations associated with this complex
genetic disorder, it indicates that miRNAs might also be
involved in the pathways that underlie disease.
Gain of a Target Site for miR-1 and miR-206
In a search for the genetic factors underlying the excep-
tional muscularity of Texel sheep, a quantitative trait lo-
cus (QTL) was identified with a major effect on muscle
mass (Clop et al., 2006). Fine mapping of this QTL re-
sulted in an interval on chromosome 2 that contained
the myostatin gene (GDF8). Because loss of myostatin
in mice, cattle, and human causes muscle doubling,
this gene seemed a likely candidate for the muscle hy-
pertrophy in Texel sheep. Although no polymorphisms
were detected in the myostatin open reading frame, 20
SNPs were found in a 10.5 kb region spanning the sheep
myostatin gene. One of these was a G-to-A transition
and appeared to be virtually Texel specific. The mutation
creates a target site for miR-1 and miR-206. Both
miRNAs are known to be strongly expressed in muscle,
which is also the primary site of myostatin expression.
Examination of the serum levels of myostatin showed
a significant reduction of the protein in Texel sheep
compared to controls. In addition, luciferase reporter
assays with both the Texel myostatin 30UTR and control
UTRs lacking the polymorphism showed a moderate,
but clear, reduction in the signal upon expression of
either miR-1 or miR-206, demonstrating direct inhibition
of the Texel myostatin gene expression via its newly ac-
quired miRNA target site. These findings indicate that
the gain of an miRNA target site might significantly affect
phenotypic variation. When searching among SNPs that
map to the 30UTR of human genes, 2490 SNPs were
found that create a potential miRNA target site, and
2597 SNPs were found that destroy a predicted target
site. Of this latter set, 483 SNPs affect a potential target
site that is perfectly conserved among 4 mammalian
species. This indicates that changes in miRNA-target in-
teractions form a potent source of phenotypic variation.
Notably, apart from destroying or creating an miRNA tar-
get site, a mutation in either a target site or an miRNA can
also modulate the regulation, i.e., the strength of the reg-
ulation may also depend on the degree of complemen-
tarity between the miRNA and the target, as has been
shown for SLITKR1 and miR-189 (Abelson et al., 2005).Several examples exist for polymorphisms in 30UTRs
that alter mRNA stability and predispose people to dis-
ease, e.g., Fang et al., 2005. Although in these cases it
is unclear if changes in miRNA binding might be associ-
ated, the above-described examples indicate that poly-
mophisms in cis-regulatory elements in 30UTRs, such as
miRNA target sites, might result in phenotypic variation
and influence susceptibility to disease.
miRNAs Associated with Viral Infection
Apart from multicellular eukaryotes, many miRNAs have
been found in viruses (Cullen, 2006; Pfeffer et al., 2004,
2005). The small size of miRNAs makes them especially
attractive as effector molecules during viral infection.
Experimental evidence for the existence of viral miRNAs
has come from several studies that detected miRNAs in
herpesviruses and polyoma viruses (Cai et al., 2005;
Grey et al., 2005; Grundhoff et al., 2006; Samols et al.,
2005; Pfeffer et al., 2004, 2005). How does a virus use
miRNAs to aid infection? A tip of the iceberg is provided
by the examination of miRNAs from the SV40 virus, one
of which induces degradation of viral mRNA coding for
T-antigens (Sullivan et al., 2005). Although this does
not affect SV40 replication, it makes viral-infected cells
less sensitive to cytotoxic T cells. Alternatively, viral
miRNAs could regulate the expression of their host
genes, but, to date, no cellular genes have been de-
scribed that are targeted by viral miRNAs. On the con-
trary, cellular miRNAs could be evolved to modulate
the replication of the virus. Indeed, the accumulation
of a retrovirus was shown to be reduced in human cells
by the activity of miR-32, indicating that the miRNA
machinery is exploited for defense against viruses
(Lecellier et al., 2005). Viruses, in turn, can use an miRNA
to facilitate their replication, as is the case for miR-122
(Jopling et al., 2005). This liver-specific miRNA directly
interacts with the 50 noncoding region of the viral ge-
nome, which is essential for viral RNA maintenance.
These examples show that miRNAs did not only evolve
to regulate gene expression programs during embryonic
development, but also coevolved with viral invaders to
restrict, or even enhance, their replication.
Concluding Remarks
The importance of miRNAs during animal development
is clear from several points. First, animals cannot live
without miRNAs. Second, there is a large repertoire of
conserved miRNAs. Third, mRNAs contain conserved
miRNA target sites. Fourth, most miRNAs are highly
abundant and exhibit striking tissue-specific expres-
sion. In addition, the role of miRNAs in several disease-
related processes is now well established. It does not
require much courage to predict that the coming years
will bring numerous examples of genetic disease
caused by dysfunction of miRNAs.
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